Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 8;33(7):545-552.
doi: 10.1097/JXX.0000000000000396.

Mast cell activation syndrome

Affiliations

Mast cell activation syndrome

Nathalie Vacheron et al. J Am Assoc Nurse Pract. .

Abstract

Mast cell activation syndrome (MCAS) is a systemic autoinflammatory disease in which mast cells behave erratically. It is unknown whether MCAS recently evolved or if it has been an unrecognized entity for years. Clinically, the patient may present in a constant to near-constant state of allergic reaction. However, the patient may also present with a variety of nonallergic symptoms. There is currently no curative treatment, and providers must prepare to be persistent in seeking symptom-management strategies. This case study describes the vast array of symptoms a typical MCAS patient may exhibit. There is a need for provider education and awareness of this disease that could affect up to 17% of the population on a spectrum from very mild to debilitating symptoms. MCAS is often either misdiagnosed or the diagnosis is greatly delayed due to a lack of provider awareness. Patients may approach primary care providers as their first line of treatment for their aberrant, mysterious symptoms, and therefore it is imperative that nurse practitioners are aware of the disease. Nurse practitioners can play a vital role in the management of MCAS using their attention to detail to recognize patterns, validate patients' experiences, and have a voice in diagnostic criteria consensus.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors report no conflicts of interest.

References

    1. Afrin L. B., Self S., Menk J., Lazarchick J. (2017). Characterization of mast cell activation syndrome. The American Journal of the Medical Sciences, 353, 207–215.
    1. Afrin L. B., Butterfield J. H., Raithel M., Molderings G. J. (2016). Often seen, rarely recognized: Mast cell activation disease—A guide to diagnosis and therapeutic options. Annals of Medicine, 48, 190–201.
    1. Akin C., Valent P. (2014). Diagnostic criteria and classification of mastocytosis in 2014. Immunology and Allergy Clinics of North America, 34, 207–218.
    1. Akin C. (2015). Mast cell activation syndromes presenting as anaphylaxis. Immunology and Allergy Clinics of North America, 35, 277–285.
    1. Akin C., Valent P., Metcalfe D. D. (2010). Mast cell activation syndrome: Proposed diagnostic criteria. The Journal of Allergy and Clinical Immunology, 126, 1099–1104.e4.

LinkOut - more resources